201 related articles for article (PubMed ID: 38116319)
21. [Effect of cisplatin alone or combined with monoclonal anti-programmed death ligand-1 antibody on lung adenocarcinoma cell line SPCA-1 and T lymphocytes].
Pan X; Xing Y; Shi M; Zhou T; Qian B; Chen Y
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):416-20. PubMed ID: 25200040
[TBL] [Abstract][Full Text] [Related]
22. High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells.
Varghese S; Samuel SM; Varghese E; Kubatka P; Büsselberg D
Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30626087
[TBL] [Abstract][Full Text] [Related]
23. Metformin-induced reduction of CCR8 enhances the anti-tumor immune response of PD-1 immunotherapy in glioblastoma.
Li Y; Liu B; Cao Y; Cai L; Zhou Y; Yang W; Sun T
Eur J Pharmacol; 2024 Feb; 964():176274. PubMed ID: 38142852
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia.
Scharping NE; Menk AV; Whetstone RD; Zeng X; Delgoffe GM
Cancer Immunol Res; 2017 Jan; 5(1):9-16. PubMed ID: 27941003
[TBL] [Abstract][Full Text] [Related]
25. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis.
Chang K; Svabek C; Vazquez-Guillamet C; Sato B; Rasche D; Wilson S; Robbins P; Ulbrandt N; Suzich J; Green J; Patera AC; Blair W; Krishnan S; Hotchkiss R
Crit Care; 2014 Jan; 18(1):R3. PubMed ID: 24387680
[TBL] [Abstract][Full Text] [Related]
26. CD4
Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929
[TBL] [Abstract][Full Text] [Related]
27. IFN-γ treatment protocol for MHC-I
Stifter K; Krieger J; Ruths L; Gout J; Mulaw M; Lechel A; Kleger A; Seufferlein T; Wagner M; Schirmbeck R
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32868392
[TBL] [Abstract][Full Text] [Related]
28. Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells.
Porichis F; Hart MG; Massa A; Everett HL; Morou A; Richard J; Brassard N; Veillette M; Hassan M; Ly NL; Routy JP; Freeman GJ; Dubé M; Finzi A; Kaufmann DE
J Immunol; 2018 Aug; 201(3):971-981. PubMed ID: 29934472
[TBL] [Abstract][Full Text] [Related]
29. Antitumor effect of CAR-T cells targeting transmembrane tumor necrosis factor alpha combined with PD-1 mAb on breast cancers.
Ba H; Dai Z; Zhang Z; Zhang P; Yin B; Wang J; Li Z; Zhou X
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36720496
[TBL] [Abstract][Full Text] [Related]
30. The PD-1 with PD-L1 Axis Is Pertinent with the Immune Modulation of Atrial Fibrillation by Regulating T Cell Excitation and Promoting the Secretion of Inflammatory Factors.
Chang G; Chen Y; Liu Z; Wang Y; Ge W; Kang Y; Guo S
J Immunol Res; 2022; 2022():3647817. PubMed ID: 35600045
[TBL] [Abstract][Full Text] [Related]
31. Secretion of human soluble programmed cell death protein 1 by chimeric antigen receptor-modified T cells enhances anti-tumor efficacy.
Zhang A; Sun Y; Wang S; Du J; Gao X; Yuan Y; Zhao L; Yang Y; Xu L; Lei Y; Duan L; Xu C; Ma L; Wang J; Hu G; Chen H; Wang Q; Hu L; Zhang B
Cytotherapy; 2020 Dec; 22(12):734-743. PubMed ID: 32684339
[TBL] [Abstract][Full Text] [Related]
32. PD-1/LAG-3 bispecific antibody potentiates T cell activation and increases antitumor efficacy.
Shi N; Zhou Y; Liu Y; Zhang R; Jiang X; Ren C; Gao X; Luo L
Front Immunol; 2022; 13():1047610. PubMed ID: 36518768
[TBL] [Abstract][Full Text] [Related]
33. Controlling Herpes Simplex Virus-Induced Immunoinflammatory Lesions Using Metabolic Therapy: a Comparison of 2-Deoxy-d-Glucose with Metformin.
Berber E; Rouse BT
J Virol; 2022 Jul; 96(14):e0068822. PubMed ID: 35862706
[TBL] [Abstract][Full Text] [Related]
34. Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy.
Liu X; Si F; Bagley D; Ma F; Zhang Y; Tao Y; Shaw E; Peng G
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36192086
[TBL] [Abstract][Full Text] [Related]
35. Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells.
Yuan LW; Jiang XM; Xu YL; Huang MY; Chen YC; Yu WB; Su MX; Ye ZH; Chen X; Wang Y; Lu JJ
Phytomedicine; 2021 Jan; 80():153394. PubMed ID: 33130472
[TBL] [Abstract][Full Text] [Related]
36. BET protein targeting suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer and elicits anti-tumor immune response.
Andrieu GP; Shafran JS; Smith CL; Belkina AC; Casey AN; Jafari N; Denis GV
Cancer Lett; 2019 Nov; 465():45-58. PubMed ID: 31473251
[TBL] [Abstract][Full Text] [Related]
37. Cryopreservation decreases receptor PD-1 and ligand PD-L1 coinhibitory expression on peripheral blood mononuclear cell-derived T cells and monocytes.
Campbell DE; Tustin NB; Riedel E; Tustin R; Taylor J; Murray J; Douglas SD
Clin Vaccine Immunol; 2009 Nov; 16(11):1648-53. PubMed ID: 19726615
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells.
Suriyo T; Fuangthong M; Artpradit C; Ungtrakul T; Sricharunrat T; Taha F; Satayavivad J
Eur J Pharmacol; 2021 Apr; 897():173960. PubMed ID: 33617828
[TBL] [Abstract][Full Text] [Related]
39. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
Hatam LJ; Devoti JA; Rosenthal DW; Lam F; Abramson AL; Steinberg BM; Bonagura VR
Clin Cancer Res; 2012 Apr; 18(7):1925-35. PubMed ID: 22322668
[TBL] [Abstract][Full Text] [Related]
40. Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer.
Kim S; Jang JY; Koh J; Kwon D; Kim YA; Paeng JC; Ock CY; Keam B; Kim M; Kim TM; Heo DS; Chung DH; Jeon YK
J Exp Clin Cancer Res; 2019 Nov; 38(1):462. PubMed ID: 31718692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
